Research Unit, Medical Department, Zealand University Hospital, Koege, Denmark.
Institute of Clinical Medicine, University of Copenhagen, Koege, Denmark.
Calcif Tissue Int. 2024 May;114(5):468-479. doi: 10.1007/s00223-024-01196-2. Epub 2024 Mar 26.
This study evaluated the performance of a vertebral fracture detection algorithm (HealthVCF) in a real-life setting and assessed the impact on treatment and diagnostic workflow. HealthVCF was used to identify moderate and severe vertebral compression fractures (VCF) at a Danish hospital. Around 10,000 CT scans were processed by the HealthVCF and CT scans positive for VCF formed both the baseline and 6-months follow-up cohort. To determine performance of the algorithm 1000 CT scans were evaluated by specialized radiographers to determine performance of the algorithm. Sensitivity was 0.68 (CI 0.581-0.776) and specificity 0.91 (CI 0.89-0.928). At 6-months follow-up, 18% of the 538 patients in the retrospective cohort were dead, 78 patients had been referred for a DXA scan, while 25 patients had been diagnosed with osteoporosis. A higher mortality rate was seen in patients not known with osteoporosis at baseline compared to patients known with osteoporosis at baseline, 12.8% versus 22.6% (p = 0.003). Patients receiving bisphosphonates had a lower mortality rate (9.6%) compared to the rest of the population (20.9%) (p = 0.003). HealthVCF demonstrated a poorer performance than expected, and the tested version is not generalizable to the Danish population. Based on its specificity, the HealthVCF can be used as a tool to prioritize resources in opportunistic identification of VCF's. Implementing such a tool on its own only resulted in a small number of new diagnoses of osteoporosis and referrals to DXA scans during a 6-month follow-up period. To increase efficiency, the HealthVCF should be integrated with Fracture Liaison Services (FLS).
本研究评估了一种椎体骨折检测算法(HealthVCF)在实际环境中的性能,并评估了其对治疗和诊断工作流程的影响。HealthVCF 用于在丹麦的一家医院识别中度和重度椎体压缩性骨折(VCF)。约有 10,000 次 CT 扫描由 HealthVCF 处理,CT 扫描阳性的 VCF 构成了基线和 6 个月随访队列。为了确定算法的性能,由专业放射技师评估了 1,000 次 CT 扫描以确定算法的性能。敏感性为 0.68(95%CI:0.581-0.776),特异性为 0.91(95%CI:0.89-0.928)。在 6 个月的随访中,回顾性队列中的 538 名患者中有 18%死亡,78 名患者已被转诊进行 DXA 扫描,而 25 名患者被诊断为骨质疏松症。与基线时已知患有骨质疏松症的患者相比,基线时未确诊患有骨质疏松症的患者死亡率更高,分别为 12.8%和 22.6%(p=0.003)。接受双膦酸盐治疗的患者死亡率(9.6%)低于其余人群(20.9%)(p=0.003)。HealthVCF 的表现不如预期,测试版本不适用于丹麦人群。根据其特异性,HealthVCF 可用于优先确定 VCF 机会性识别的资源。在 6 个月的随访期间,单独实施这样的工具仅导致少数新诊断为骨质疏松症和转诊进行 DXA 扫描。为了提高效率,HealthVCF 应与骨折联络服务(FLS)集成。